News & Articles

Partnership seeks to improve patient outcomes and experiences through novel digital and diagnostic solutions

Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine

Guest editorial article by Vikas Singh, PhD, and Thomas Beadnell, PhD, from Eurofins

Learn how a cutting-edge tool is being used by drug development scientists to optimize preclinical studies

New social media channels will better serve the clinical community by making it even easier to stay up to date

Researchers have uncovered how hormones profoundly affect our immune systems, explaining why men and women are affected by diseases differently

Brand new event designed to bring together everyone working in the clinical laboratory science industry

Expanding capabilities and streamlining experimental workflows

New blood test developed by Siemens Healthineers in collaboration with Novartis aims to improve the management of MS

Learn about clinical aspects of Graves’ Disease and the use of TSH immunoglobulin assay for diagnosis and monitoring

A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways

SelectScience clinical webinars can be added to HCPC and IBMS portfolios as evidence of CPD

Discover how modern quality control (QC) principles can enhance operational efficiency and healthcare outcomes

The inaugural BOOM Summit successfully convened 500 participants from across Europe at Messe Basel

The Anti-Müllerian Hormone Assay reveals a patient's ovarian reserve information

ASTar enables rapid therapeutic response to sepsis directly from a positive blood culture

Discover the human side of laboratory medicine with our #Lab4Life editorial feature

New Aptiva® APS IgG and APS IgM reagents enable early diagnosis of Antiphospholipid Syndrome in hard-to-diagnose autoimmune disease

Immunology expert, Dr. Anna Majowicz, shares how Spark Therapeutics research is helping tackle immunogenicity challenges in AAV-mediated gene therapy

David Wells, CEO of the IBMS, discusses the Institute’s plans to ensure the future of biomedical science careers

New study finds that persistent COVID-19 infections are surprisingly common, with around one to three in every 100 infections lasting a month or longer

Leveraging Quanterix’s Simoa platform, researchers lay the groundwork for pre-symptomatic Alzheimers diagnosis, guided treatment, and accelerated clinical drug trials

Examine the benefits and logistics of transitioning your program from traditional site-based blood collection to remote sampling